home / stock / dxcm / dxcm articles

DXCM Articles, DexCom Inc. - From 04/26/24

Stock Information
Company Name: DexCom Inc.
Stock Symbol: DXCM
Market: NASDAQ
Website: dexcom.com
Menu
DXCM DXCM Quote DXCM Short DXCM News DXCM Articles DXCM Message Board
Get DXCM Alerts

News, Short Squeeze, Breakout and More Instantly...
Intel Reports Weak Sales, Joins Boyd Gaming, Atlassian And Other Big Stocks Moving Lower In Friday's Pre-Market Session | Benzinga

U.S. stock futures were higher this morning, with the Nasdaq futures gaining over 150 points on Friday. Shares of Intel Corporation (NASDAQ:INTC) s...
$1000 Invested In DexCom 5 Years Ago Would Be Worth This Much Today | Benzinga

DexCom (NASDAQ:DXCM) has outperformed the market over the past 5 years by 23.93% on an annualized basis producing an average annual return of 35.38...

Micron, Dropbox And 2 Other Stocks Insiders Are Selling | Benzinga

The Nasdaq 100 closed lower by around 0.1% on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it...

DexCom Is 'Expanding Rapidly' With Multi-Year Runway Ahead, Bullish Analyst Says | Benzinga

DexCom Inc’s (NASDAQ: DXCM) Stelo Glucose Biosensor System has been approved by the Food and Drug Administration (FDA) as the first over-the-...
Palantir Technologies, SL Green Realty And A Healthcare Stock On CNBC's 'Final Trades' | Benzinga

On CNBC’s "Halftime Report Final Trades," Jenny Harrington of Gilman Hill Asset Management named SL Green Realty Corp. (NYS...

FDA Approval For DexCom's Stelo Opens Continuous Glucose Monitoring To Masses, Analyst Expects Competitive Pricing Against Abbott's | Benzinga

Tuesday, the FDA approved DexCom Inc’s (NASDAQ:DXCM) Stelo Glucose Biosensor System as the first over-the-counter (OTC) contin...

FDA Approves Dexcom's Stelo As First Glucose Monitoring Device Without Prescription | Benzinga

Tuesday, the FDA approved DexCom Inc’s (NASDAQ:DXCM) Stelo Glucose Biosensor System as the first over-the-counter (OTC) contin...
Campbell Soup, Box And 3 Stocks To Watch Heading Into Wednesday | Benzinga

With U.S. stock futures trading mostly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Wall...

Continuous Glucose Monitor Maker Dexcom's Q4 Profit Triples On Volume Growth And New Customer Additions | Benzinga

Thursday, after-hours Dexcom Inc (NASDAQ:DXCM) reported fourth-quarter 2023 earnings with sales of $1.03 billion, up 27% Y/Y (+26% on an ...

If You Invested $100 In This Stock 15 Years Ago, You Would Have $13,000 Today | Benzinga

DexCom (NASDAQ:DXCM) has outperformed the market over the past 15 years by 26.47% on an annualized basis producing an average annual return of 39.0...
Previous 10 Next 10